Skip to main content
TipRanks
Go Ultimate75% OFF

Volex plc (64K) AI Stock Analysis

0 Followers
DE:64K

Volex plc

(XETRA:64K)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong revenue growth and operating leverageVolex has built substantial scale through sustained multi-year revenue growth, while higher operating margins show improving leverage as the business expands. This combination can strengthen earnings capacity, support reinvestment, and improve resilience over the next several quarters.
Negative Factors
Data-center customer concentrationDependence on one hyperscaler makes an important growth driver vulnerable to changes in that customer's purchasing, deployment timing, or sourcing decisions. Even with broader diversification, concentration could make revenue growth and capacity utilization less predictable.

Volex plc (64K) vs. iShares MSCI Germany ETF (EWG)

-20%0%20%40%60%80%100%DE:64K+39.44%EWG+4.05%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 941.90M
Dividend Yield
0.87%
Average Volume (3M)
9,871
Price to Earnings (P/E)
11.6
Beta (1Y)
0.89
Revenue Growth
14.03%
EPS Growth
80.71%
Country
Germany
Employees
12,500
Sector
Industrials
Sector Strength
63
Industry
Electrical Equipment & Parts

Volex plc Business Overview & Revenue Model

Company Description

Volex plc manufactures and sells power and connectivity in North America, Europe, and Asia. It provides integrated manufacturing services, such as PCB assembly, box build, and complex cable assemblies; electric vehicle charging solutions; consumer ca...

Volex plc Earnings Call Summary

Earnings Call Date:Jun 25, 2026(Q4-2026)|% Change Since:-4.67%|Next Earnings Date:Jul 01, 2027
Earnings Call SentimentPositive

The call presents a strongly positive operational and financial performance: record revenue, substantial organic growth, margin expansion above guidance, doubled data center revenues, improved returns (ROCE 21%) and reduced leverage (0.8x). Management set an ambitious, clearly articulated medium-term plan to reach $2 billion revenue and 12% operating margin. Key risks were acknowledged—customer concentration in data centers, declines in Consumer Electricals and Medical (destocking), higher working capital, and some macro pressures (freight, inflation, FX), as well as residual selling related to the AIM-to-Main move and elevated acquisition valuations. Overall, the positives (robust growth, margin and cash/return metrics, strategic clarity and momentum) materially outweigh the identifiable challenges.

Positive Updates

Record Revenue and Strong Organic Growth
Revenue of $1.243 billion, up 14.4% year-on-year (organic growth 14.2%), delivering the five-year plan a full year early and surpassing the $1.2 billion target.

Negative Updates

Customer Concentration Risk in Data Centers
A material portion of the data center growth was driven by a single hyperscaler customer, creating concentration risk despite management noting diversification outside the two largest customers and that no other customer exceeds ~4% of revenue.

Company Guidance

Volex's guidance set a clear medium‑term target to reach $2.0bn of revenue at a 12% underlying operating margin (implying roughly $240m of underlying operating profit), driven by about $500m of organic growth plus ~$300m from disciplined capability‑led acquisitions; this implies ~200bps of margin expansion from FY26's 10.2% (FY26 revenue $1.243bn, organic growth 14.2%, underlying operating profit $127.3m, underlying EBITDA $164m up 22%, ROCE 21%, underlying basic EPS $0.435 up 20%). Capital allocation priorities remain organic first, then selective M&A (post‑acquisition ROCE target ≥15% within two years and ~15% operating margin threshold), with typical capex of 3–4% of revenue (FY26 capex $35m, 2.8% of revenue; projects target <2‑year payback), cash conversion 63.9% (pre‑capex >90%), free cash flow $42m, and covenant leverage 0.8x. Near‑term guidance: trading into FY27 is “strong and in line” with expectations, data‑center demand was sustained into Q1 FY27, Medical should stabilise in FY27, and the company expects further margin improvement from site rationalisation and centres of excellence.

Volex plc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:64K against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:LUCEGB:LUCE84OutperformGBP 296.69M14.6219.62%3.27%11.48%46.33%
GB:TFWGB:TFW76OutperformGBP 291.36M10.9014.19%3.82%-1.30%10.28%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
GB:DIAGB:DIA49NeutralGBP 250.12M25.4624.61%―-5.32%0.72%
GB:XPPGB:XPP49NeutralGBP 445.94M-51.69-4.89%―-1.21%46.27%
GB:LPAGB:LPA48NeutralGBP 11.36M49.421.42%―19.87%―

* Industrials Sector Average

Performance Comparison

0%50%100%DE:64KGB:DIAGB:LPAGB:LUCEGB:TFWGB:XPPDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:64K and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:64KVolex plc6.351.7638.22%
GB:DIADialight plc620.00295.0090.77%
GB:LPALPA Group plc86.0045.50112.35%
GB:LUCELuceco plc191.0065.0651.65%
GB:TFWFW Thorpe Plc260.00-21.55-7.65%
GB:XPPXP Power1630.00730.0081.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.